DTIL vs. SAGE
DTIL (Precision BioSciences, Inc.) and SAGE (Sage Therapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. At a 0.31 correlation, their price movements are largely independent.
Performance
DTIL vs. SAGE - Performance Comparison
Loading charts...
Returns By Period
DTIL
- 1D
- -4.43%
- 1M
- -20.84%
- YTD
- 45.19%
- 6M
- 19.37%
- 1Y
- 17.28%
- 3Y*
- -35.49%
- 5Y*
- -55.07%
- 10Y*
- —
SAGE
- 1D
- —
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
DTIL vs. SAGE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
DTIL Precision BioSciences, Inc. | 45.19% | 9.19% | -65.21% | -69.33% | -83.92% | -11.27% | -39.96% | -20.36% |
SAGE Sage Therapeutics, Inc. | 0.00% | 59.85% | -74.94% | -43.18% | -10.34% | -50.83% | 19.84% | -54.83% |
Correlation
The correlation between DTIL and SAGE is -0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.01 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.11 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.30 |
Correlation (All Time) Calculated using the full available price history since Mar 29, 2019 | 0.31 |
The correlation between DTIL and SAGE shifts across timeframes, from -0.01 (1 year) to 0.31 (all time), reflecting how their relationship changes across market environments.
Fundamentals
DTIL:
$148.79M
SAGE:
$543.46M
DTIL:
-$2.95
SAGE:
-$4.81
DTIL:
2.02
SAGE:
7.72
DTIL:
1.96
SAGE:
1.47
DTIL:
$45.07M
SAGE:
$70.41M
DTIL:
$32.19M
SAGE:
$63.04M
DTIL:
-$30.02M
SAGE:
-$302.71M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DTIL vs. SAGE — Risk / Return Rank
DTIL
SAGE
DTIL vs. SAGE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Precision BioSciences, Inc. (DTIL) and Sage Therapeutics, Inc. (SAGE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| DTIL | SAGE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.10 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 0.30 | — | — |
| Martin ratioReturn relative to average drawdown | 0.56 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| DTIL | SAGE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.25 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.70 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.55 | — | — |
Drawdowns
DTIL vs. SAGE - Drawdown Comparison
Loading charts...
Drawdown Indicators
| DTIL | SAGE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.39% | — | — |
Max Drawdown (1Y)Largest decline over 1 year | -58.54% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -85.40% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -99.16% | — | — |
Current DrawdownCurrent decline from peak | -98.98% | — | — |
Average DrawdownAverage peak-to-trough decline | -77.65% | — | — |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 30.78% | — | — |
Volatility
DTIL vs. SAGE - Volatility Comparison
Loading charts...
Volatility by Period
| DTIL | SAGE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.95% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 49.88% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 68.81% | — | — |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 79.38% | — | — |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 84.87% | — | — |
Dividends
DTIL vs. SAGE - Dividend Comparison
Neither DTIL nor SAGE has paid dividends to shareholders.
Financials
DTIL vs. SAGE - Financials Comparison
This section allows you to compare key financial metrics between Precision BioSciences, Inc. and Sage Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
DTIL and SAGE have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for DTIL and SAGE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer